Projects per year
Fingerprint
Dive into the research topics where Joleen M Hubbard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
Evaluation of Safety, Immunogenicity, and Preliminary Efficacy of PolyPEPI1018 Vaccine with CDx in Subjects with Metastatic Colorectal Cancer
Hubbard, J. M. (PI)
8/15/20 → …
Project: Research project
-
Comparison of survival outcomes for patients with Lynch vs non-Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy
Eslinger, C., Walden, D., McGary, A., Emiloju, O., Ahn, D., Sonbol, M. B., Bekaii-Saab, T., Zhu, M., Hubbard, J. & Wu, C., Feb 15 2025, In: Cancer. 131, 4, e35756.Research output: Contribution to journal › Article › peer-review
-
Onvansertib in Combination with Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial
Ahn, D. H., Ridinger, M., Cannon, T. L., Mendelsohn, L., Starr, J. S., Hubbard, J. M., Kasi, A., Barzi, A., Samuëlsz, E., Karki, A., Subramanian, R. A., Yemane, D., Kim, R., Wu, C. C., Croucher, P. J. P., Smeal, T., Kabbinavar, F. F. & Lenz, H. J., Mar 1 2025, In: Journal of Clinical Oncology. 43, 7, p. 840-851 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot
Tevaarwerk, A. J., Karam, D., Gatten, C. A., Harlos, E. S., Maurer, M. J., Giridhar, K. V., Haddad, T. C., Alberts, S. R., Holton, S. J., Stockham, A., Leventakos, K., Hubbard, J. M., Mansfield, A. S., Halfdanarson, T. R., Chen, R., Jochum, J. A., Schwecke, A. S., Eiring, R. A., Carroll, J. L. & Riaz, I. B. & 3 others, , Jan 1 2025, In: Cancer. 131, 1, e35304.Research output: Contribution to journal › Article › peer-review
-
Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatinand irinotecan-based chemotherapy and biologics in the us
Paly, V. F., Dasari, A., Hubbard, J., Bekaii-Saab, T., Padukkavidana, T. & Hernandez, L., 2024, In: Journal of Comparative Effectiveness Research. 13, 8, e240084.Research output: Contribution to journal › Article › peer-review
Open Access -
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
Saberzadeh-Ardestani, B., Jones, J. C., McWilliams, R. R., Tougeron, D., Halfdanarson, T. R., Guimbaud, R., Hubbard, J. M., Fleccia, C., Shi, Q., Alouani, E., Sonbol, M. B., Ticku, J., Jin, Z., Taieb, J. & Sinicrope, F. A., Jan 2024, In: European Journal of Cancer. 196, 113433.Research output: Contribution to journal › Article › peer-review